First published on December 25, 2020
Bill Gates is actively financing and promoting new untested vaccines supposed to keep us at least somewhat safe from a ‘ghastly” death from the novel coronavirus and supposedly allow us to resume somewhat “normal” lives. The Pharma giant Pfizer has now announced what they claim were spectacular results in initial human tests. They use an experimental technology known as gene editing, specifically mRNA gene-editing, something never before used in vaccines. Before we rush to get jabbed in hopes of some immunity, we should know more about the radical experimental technology and its lack of precision.
The financial world went ballistic on November 9 when the pharma giant Pfizer and its German partner, BioNTech, announced in a company press release that it had developed a vaccine for Covid19 that was “90%” effective.
The controversial US head of NIAID, Tony Fauci (right) rushed to greet the news and the EU announced it had purchased 300 million doses of the costly new vaccine. If you believe financial markets, the pandemic is all but past history.
However it seems Albert Bourla, the CEO of Pfizer, doesn’t share the confidence of his own claims. On the day his company issued its press release on the proposed vaccine trials, he sold 62% of his stock in Pfizer, making millions profit in the deal. He made the sell order in a special option in August so it would not appear as “insider selling”, however he also timed it just after the US elections and the mainstream media illegitimately declared Joe Biden President-elect. It seems from appearances that Bourla had a pretty clear conflict of interest in the timing of his press release on the same day.
Bourla lied and denied to the Press that his company had received any funds from the Trump Administration to develop the vaccine when it came out they contracted in summer to deliver 100 million doses to the US Government. Further adding to the suspect actions of Pfizer was the fact the company first informed the team of Joe biden rather than the relevant US government agencies.
But this is far from the only thing alarming about the much-hyped Pfizer announcement.